HomeMarkets Markets Moderna’s Personalized mRNA Cancer Vaccine Shows Promising Results in Early Trial By news December 21, 2022 0 58 FacebookTwitterPinterestWhatsApp Moderna’s personalized cancer vaccine was shown to reduce the risk of recurrence in patients with stage 3 or 4 melanoma in a phase 2b clinical trial. …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected159,281FansLike406,809FollowersFollow2,160SubscribersSubscribe Latest Articles Hot Items Powell Interview Here Markets The Technicals Vs The Fundamentals. Which Is Right? Markets Credit Suisse Postpones Today’s Bonus Pool Meeting With Top Bankers Markets The Sound Of Even More Balloons Bursting Markets Top Dollar Tuesday – Indexes Holding Up Well Against Rising Currency Load more